Health-care companies rose as venture-capital investors unveiled activity in genetic firms.
SoftBank Group plans to lead an investment of nearly $1.2 billion into genetic-testing provider Invitae, as the Japanese technology giant ramps up an effort to put more money into public companies.
Startup Inscripta raised $150 million in new venture capital to roll out a genome-editing instrument that could help researchers in healthcare and other industries biologically engineer new products.
Newly reported Covid-19 cases in the U.S. fell by nearly half on Sunday from a day earlier to 34,000, while the number of deaths recorded also dropped sharply. The increasingly rapid rollout of vaccines appears to be slowing the rate of Covid transmission in much of the U.S.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.